Filing Manager
MILLENNIUM MANAGEMENT LLC
Reporting Manager
Millennium Management LLC
Symbol
INDV
Shares outstanding
126,488,316 shares
Disclosed Ownership
4,806,556 shares
Ownership
3.8%
Form type
SCHEDULE 13G
Filing time
23 Mar 2026, 17:19:04 UTC
Date of event
17 Mar 2026
Previous filing
22 Dec 2025

Sponsored

Quoteable Key Fact

"MILLENNIUM MANAGEMENT LLC disclosed 3.8% ownership in Indivior Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (INDV) on 17 Mar 2026."

Quick Takeaways

  • MILLENNIUM MANAGEMENT LLC filed SCHEDULE 13G for Indivior Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (INDV).
  • Disclosed ownership: 3.8%.
  • Date of event: 17 Mar 2026.

What Changed

  • Previous schedule filing date: 22 Dec 2025.
  • Current filing was accepted on 23 Mar 2026, 17:19.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Millennium Management LLC 3.8% 4,806,556 0 4,806,556 /s/ Gil Raviv Gil Raviv, Global General Counsel
Millennium Group Management LLC 3.8% 4,806,556 0 4,806,556 /s/ Gil Raviv Gil Raviv, Global General Counsel
Israel A. Englander 3.8% 4,806,556 0 4,806,556 /s/ Israel A. Englander Israel A. Englander